The infectious disease diagnostics market is driven by unprecedented outbreaks of infections and rising awareness of people and policy makers towards the vital use of diagnostic tools to control widespread outbreaks.
For a surgeon to perform at their peak, they need the highest quality equipment. For this reason, Sony developed the PVM-2551MD 24.5” monitor.
In 2011, among Germany’s 82 million people 69.5 million holiday trips were made, each lasting at least five days; 47.8 million (68.8%) of these were abroad.
Surgeons at a leading UK hospital are pioneering robotic endovascular surgery to treat patients with complex conditions.
Over the last five years the tiniest particles have attracted large attention in relation to the diagnosis and treatment of cardiovascular disease. Indeed, as in other medical disciplines, nanotechnology is advancing in cardiology despite as yet insufficient research on the extent of its effect and double blind studies to confirm findings
Initially limited to the aortic valve, interventions are becoming routine for the mitral valve. Thus the only available product has enjoyed huge commercial success – until now. Report: Holger Zorn
Cardiologists are increasingly concerned about patients with persistent hypertension demanding a new technique, in the absence of clinical proof of its long-term benefit. As more related devices are launched, John Brosky reports on the procedure, drawbacks, and a potential €2 billion market.
A new generation of cardiovascular implantable electronic devices (CIEDs) includes the Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronisation Therapy Defibrillator (CRT-Ds) and Cardiac Resynchronisation Therapy Pacemakers (CRT-Ps). Professor W R Bauer at University Hospital Würzburg has been significantly involved in their development, EH Editor Ralf Mateblowski to ask him about…
Modern wars will be fought in the cyber zone, targeting an enemy's communications technology to cause critical damage; a Tel Aviv University researcher suggests to employ similar tactics in the battle against cancer.
As part of the recent annual Heathcare Summit organised by Sole 24 ORE in Milan, Italy, Carestream Health sponsored a round table discussion on cloud computing. The Summit is an established event in Italy and is attended by Government and regional officials and companies contracted by the Italian Ministry of Health. Carestream is one of the world’s leading providers of cloud infrastructure,…
Carestream Health brought fresh innovations to ECR 2012, among them the DRX-Revolution that shares the same DRX-1/DRX-1C wireless detectors as others in the firm’s DRX family. In our recent European Hospital discussion, Ulf Andersson, Director of marketing and development at Carestream Health in Europe, explained why he considers this mobile X-ray device and the firm’s DRX series to be so…
In a paper published in ”Nature Biotechnology” on the 22nd of July of 2012 Harvard researchers explain how making a jellyfish from rat DNA can help to solve cardiac problems.
For radiologists and radiology technologists, this development will mean advantages in workflow and documentation of injection parameters.
This congress was a celebration, marking 20 years since the founding of ESTI, which began as a small group of founding members and has grown to become thriving society contributing to the education in Europe and encouraging worldwide.
The Johns Hopkins University (JHU), America’s first research university, in Baltimore, Md., USA, and the Fraunhofer Heinrich Hertz Institute (HHI), a mobile and information technology development leader based in Berlin, Germany, have signed a Memorandum of Understanding to jointly research the innovative medical applications of integrated optical sensors: small, highly sensitive devices with…
A new report from Siemens Financial Services (SFS) shows that annual growth rates for global medical equipment leasing and renting have now outstripped growth in the medical device market as a whole. The global medical leasing market is currently expanding at a rate of 6.50%, outpacing the 4.98% growth rate of the global medical device market.
Meeting with EH editor Brigitte Dinkloh, Congress Secretary Professor Alexis Ulrich MD (left), Assistant Medical Director at the Clinic for General, Visceral and Transplant Surgery at the University of Heidelberg, outlined the scientific programme, discussed some impressive advances in surgical procedures, and explained why the gathering bears the slogan Surgery in Partnership.
Computed tomography (CT) has become central to the diagnosis and characterisation of coronary artery disease (CAD) and, in the future, could even supplant invasive coronary angiography as the technology increases sensitivity.
Three radiologists, who focused on different clinical applications using different diagnostic techniques, have reached the same conclusion: the next-generation of ultrasound brings new capabilities for detection, differentiation and advanced diagnosis of disease, John Brosky reports.
The ability to ‘fly-thru’ organs with 3-D reconstruction is the leading edge for new ultrasound features on board Toshiba’s new Aplio 500, John Brosky reports.
Following last year’s acquisition of Aloka Co Ltd by Hitachi Medical Corporation, their powerful combination in Hitachi Aloka Medical Ltd has united next generation technologies in high-end ultrasound for use by family physicians and small practices.
The ACEM Medical Company’s OT - System, which includes the OT-STARLED 7 and STARLED 5, is based on advanced LED (light emitting diode) technology which, the Italian manufacturer reports, ‘…guarantees the best work conditions for surgeons and medical teams in the operating rooms.’
A new competitively priced scanner promises to make 3-tesla MRI more accessible to a wider range of institutions, according to Siemens Healthcare.
Among the area’s top cardiac and vascular disease specialist hospitals, Arizona Heart has invested in several technological advancements over the past year, including Ziehm Imaging’s digital flat panel C-arms for its three advanced technology suites.
The benfit of breast cancer screening for women over aged 50 is beyond doubt. However, what does a systematic search yield for breast cancer in women aged between 40 and 49? This question, which remains controversial, was raised again at ECR 2012.